Skip to content

Protected: Studies

A Multicenter, Observational, Open-Label, Single-Arm Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JCV Antibody Negative Patients

Calendar Name STRIVE
Description This is a phase 4, single-country, multicenter, open-label, prospective, observational study for patients with relapsing forms of multiple sclerosis (MS) who are initiating treatment with Tysabri. The
PI Roumen Balabanov
People Benjamin Joslin
Business Administrator -
Resources 3T Trio (Neuro)
IRB STU00204753
Start Date 2017-09-18
End Date
Chart String 640-5210100-60047247
Affiliates No